Home › Xspray Microparticles AB Announces Positive Phase I Data for HyNap Nilotinib
 

Keywords :   


Xspray Microparticles AB Announces Positive Phase I Data for HyNap Nilotinib

2014-05-09 06:30:00| Appliances - Topix.net

May 8, 2014. XSpray Microparticles AB today announced that its proprietary HyNapa formulation of nilotinib demonstrated significantly improved uptake and reduced food interaction in a Phase I clinical trial compared to previously reported data for the commercial available formulation of nilotinib.

Tags: data positive phase announces

Category:Consumer Goods and Services

Latest from this category

All news
16.11Record numbers seek help with water bills
16.11Billions at stake in court battle over North Sea oil
15.11China megaport opens up Latin America as wary US looks on
15.11China megaport opens up Latin America as wary US looks on
15.11Post Office scandal: Who knew what and when?
15.11Mortgage costs rise despite interest rate cut
15.11Health stocks hit after Trump taps RFK Jr for top job
15.11X users jump to Bluesky - but what is it and who owns it?
Consumer Goods and Services »
16.11HestraFallLine3
16.11GBA
16.11 SKY PAD 3.0 XL
16.1125th
16.112022taxDVD
16.11
16.11
16.11 e
More »